Bridge^TM Rapamycin Target Eluting Vertebral Artery Stent System is reshaping vertebral stenosis treatment by adopting unique groove-binding single-sided drug coating.

Controlled and Targeted Drug Release

The Rapamycin (Sirolimus) loaded in the stent groove inhibits the proliferation of smooth muscle cells at the patient's lesion to a certain extent to reduce restenosis in the long term, while minimizes the occurrence of late stent thrombosis through the application of the single-sided coating design.

Balanced Flexibility and Fatigue Resistance with Hybrid Structure

The “n” shape connector reduces stent foreshortening, while the “S+long axis” shape connector improves stent conformability.

The Sine-wave open cell structure and cobalt-based alloy guarantee adequate radial force for vertebral stenosis.

Easy Navigation with Rapid Exchange Delivery System

The delivery system is a rapid exchange balloon dilation catheter with low crossing profile and ultra-short tip, ensuring atraumatic and fast access to target lesion.